European Journal of Clinical Pharmacology

, Volume 14, Issue 3, pp 213–220 | Cite as

Utilization of antidiabetic drugs in the island of gotland, sweden: Agreement between wholesale figures and prescription data

  • U. Bergman
Originals

Summary

In a comparison of three European countries Sweden utilized more antidiabetic drugs than Northern Ireland and Norway. Swedish wholesale figures for a quarter of a year used for the comparison were based on “daily doses”/1000 inhabitants/day. In order to validate the Swedish figures, a defined geographical area was investigated in 1972–1973, the island of Gotland with 54000 inhabitants. Antidiabetic drugs distributed on a wholesale basis were compared with those distributed on a prescription basis. Additional information was gathered (interviews, questionnaires, hospital records etc.) from a sample of patients (n=54) and their prescribing doctors (n=37). There was good agreement between the wholesale and prescription figures for oral antidiabetic drugs over a three month period (30.0 vs 29.8 “daily doses”/1000 inhabitants/day), but this did not apply to insulin (5.9 vs 7.2) unless a longer time period was studied. The average daily doses prescribed were higher than the theoretically derived “daily doses”. Combination antidiabetic drug therapy was preseribed for 28% of the patients. Thirteen different oral antidiabetics were issued during the study period, four of which constituted 90% of the total. Phenformin, the second most commonly prescribed oral antidiabetic drug was prescribed by 33 doctors, and metformin was prescribed by only 14 doctors. Few patients were treated with diet alone and few doctors could obtain assistance from a dietician. There was little or no evidence that patients failed to comply with the prescriptions, but by contrast they adhered poorly to written dietary instructions.

Key words

Diabetes antidiabetic drugs drug utilization prescribing habits geographical differences methodology 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bergman, U., Elmes, P., Halse, M., Halvorsen, T., Hood, H., Lunde, P. K. M., Sjöqvist, F., Wade, O., Westerholm, B.: The measurement of drug consumption. Drugs for diabetes in Northern Ireland, Norway and Sweden. Europ. J. clin. Pharmacol.8, 83–89 (1975)Google Scholar
  2. 2.
    Boethius, G.: Recording of drug prescriptions in the county of Jämtland, Sweden: Pattern of drug usage in 16600 individuals 1970–75. Acta med. scand.202, 241–251 (1977)Google Scholar
  3. 3.
    Kočárek, A.: Epidemiologie úplavice cukrové v CSR a zpusob jejího lécní v soucasnosti, s výhledem do roku 1990. In: Racionalni Terapie Insulinem. (J. Solich, J. Rostlapil eds.), pp 187–202. Léciva, Hradec Králové (1976)Google Scholar
  4. 4.
    Drug Utilization Studies — Methods and Applications. U. Bergman, A. Grímsson, B. Westerholm. (eds.) Copenhagen: World Health Organization 1978 (in press)Google Scholar
  5. 5.
    Baksaas Aasen, I., Lunde, P. K. M., Halse, M., Halvorsen, I. K., Skobba, T. J., and Strømnes, B.: Drug Dose Statistics. List of defined doses for drugs registered in Norway. Ed. by the Norwegian Medicinal Depot, Oslo (1975)Google Scholar
  6. 6.
    Stiká, L., Hovorova, M., Kratochvil, J.: Automated processing of medical prescriptions. Activ. nerv. sup. (Praha)13, 228–229 (1971)Google Scholar
  7. 7.
    Stiká, L., Winkler, V., Diamantová, O., Wimmerová, K., Ondrátková, M., Plechatová, H.: Spotŕeba insulinu a perorálnich antidiabetik ve d vou praźských obvodech a v jednotlivých krajich CSSR. in Farmakoterap. Zprávy, Supl 1, pp 179–185 (1975)Google Scholar
  8. 8.
    Sjöberg, B.: The Gotland investigation 1965. Svensk Farm. Tidskr.71, 8–11 (1967)Google Scholar
  9. 9.
    Watkins, J., Roberts, D., Williams, F., Martin, D., and Coyle, V.: Observation of medication errors made by diabetic patients in the home. Diabetes16, 882–885 (1967)Google Scholar
  10. 10.
    Bergman, U., Sjöqvist, F., Söderhielm, L.: Use of digoxin in a low density population area in Sweden. Europ. J. clin. Pharmacol.10, 19–24 (1976)Google Scholar
  11. 11.
    Wade, O. L., Hadden, D. R., Hood, H.: The prescribing of drugs in the treatment of diabetes. Brit. J. prev. soc. Med.27, 44–48 (1973)Google Scholar
  12. 12.
    Kristoferson, K., Wessling, A.: Tre års receptundersökningar. Svensk Farm. Tidskr.81, 309–316 (1977)Google Scholar
  13. 13.
    Lindgren, S.: Mjölksyreacidos vid behandling med fenformin. Läkartidningen66, 3705–3714 (1969)Google Scholar
  14. 14.
    Alling, B., Steen, B.: Analyser av mjölksyra och acetatättiksyra i artärblod via mjölksyraacidos hos fenforminbehandlad diabetiker. Läkartidningen67, 4914–4915 (1970)Google Scholar
  15. 15.
    Rapport om läkemedelsbiverkningar XIII. Läkartidningen67, 5883–5884 (1970)Google Scholar
  16. 16.
    Böttiger, L. E.: Mjölksyraacidos och biguanider — en översikt. Läkartidningen70, 3463–3464 (1973)Google Scholar
  17. 17.
    Andersson, B., Östman, J.: Antidiabetika. Farmakologi, Klinik. Socialstyrelsens kommitté för läkemedelsinformation, 2:I Oktober 1974Google Scholar
  18. 18.
    Westerholm, B.: Adverse drug reactions. A problem for drug regulatory agencies. Int. J. clin. Pharmacol.7, 183–189 (1973)Google Scholar
  19. 19.
    Östman, J.: Behandling med sulfonylureapreparat. In: Nordiskt Symposium. Diabetes och dess behandling. L. Hallberg, G. Blohmé (eds.). Mölndal: A. Lindgren & Söner 1975Google Scholar
  20. 20.
    Rundabordssamtal om diabetesbehandlingen i Norden. Förvånande skillnader i terapivalet. För litet diet, för mycket tabletter? Nord. Med.91, 171–181 (1976)Google Scholar
  21. 21.
    Bergman, U., Boman, G., Wiholm, B.-E.: Epidemiology of adverse drug reactions to phenformin and metformin. Br. med. J.1978/II, 464–466Google Scholar
  22. 22.
    Bergman, U.: International comparisons of drug utilization. Antidiabetic drugs in seven European countries. In: Drug Utilization Studies — Methods and Applications. U. Bergman, A. Grímsson, B. Westerholm (eds.). Copenhagen World Health Organization 1978 (in press)Google Scholar
  23. 23.
    Nordic Statistics on Medicines. Statistical Reports of the Nordic Countries. M. Granat, B. Westerholm (eds.) Helsinki 1978Google Scholar

Copyright information

© Springer-Verlag 1978

Authors and Affiliations

  • U. Bergman
    • 1
  1. 1.Department of Clinical Pharmacology of the Karolinska InstituteHuddinge University HospitalHuddingeSweden

Personalised recommendations